Correlation Between CRISPR Therapeutics and Annaly Capital

Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Annaly Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Annaly Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CRISPR Therapeutics AG and Annaly Capital Management,, you can compare the effects of market volatilities on CRISPR Therapeutics and Annaly Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Annaly Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Annaly Capital.

Diversification Opportunities for CRISPR Therapeutics and Annaly Capital

0.0

Correlation Coefficient

CRISPR Therapeutics  Annaly Capital

Pay attention - limited upside

The 3 months correlation between CRISPR and Annaly is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Annaly Capital Management, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annaly Capital Manag and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Annaly Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annaly Capital Manag has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Annaly Capital go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Annaly Capital

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to under-perform the Annaly Capital. In addition to that, CRISPR Therapeutics is 2.49 times more volatile than Annaly Capital Management,. It trades about -0.24 of its total potential returns per unit of risk. Annaly Capital Management, is currently generating about -0.13 per unit of volatility. If you would invest  11,692  in Annaly Capital Management, on October 4, 2024 and sell it today you would lose (365.00) from holding Annaly Capital Management, or give up 3.12% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	89.47%
Values	Daily Returns

CRISPR Therapeutics AG  vs.  Annaly Capital Management,

CRISPR Therapeutics

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Annaly Capital Manag

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Annaly Capital Management, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Annaly Capital is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with CRISPR Therapeutics and Annaly Capital

The main advantage of trading using opposite CRISPR Therapeutics and Annaly Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Annaly Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annaly Capital will offset losses from the drop in Annaly Capital's long position.

The idea behind CRISPR Therapeutics AG and Annaly Capital Management, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..